Ann: US Patent Issued - BARD1 Patent Family Lung Cancer Diagnosis, page-66

Certainly going to be interesting end to the year . Was the rise on Friday due to the approval of this US patent for Lung cancer or was it the penny dropping on the potential results this year on transferring Breast cancer SubB2M to the commercially recognised platform as referred to in the FNN on line presentation by Learnne Hinch .Or even a potential agreement with one of the major NA labs to take it to the next stage as also referenced . Next week will either be a fizzer or potential to jump quickly again with the right news some time soon.
With work streams on breast , ovarian, prostate and lung cancer early detection they are certainly in the money space .